Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1991 5
1992 2
1993 3
1994 1
1996 2
1997 5
1998 4
1999 3
2001 6
2002 7
2003 10
2004 3
2005 11
2006 9
2007 7
2008 8
2009 11
2010 20
2011 24
2012 15
2013 25
2014 28
2015 18
2016 13
2017 22
2018 17
2019 27
2020 30
2021 36
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

331 results
Results by year
Filters applied: . Clear all
Page 1
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Rini BI, et al. Among authors: ou yc. Lancet. 2011 Dec 3;378(9807):1931-9. doi: 10.1016/S0140-6736(11)61613-9. Epub 2011 Nov 4. Lancet. 2011. PMID: 22056247 Clinical Trial.
Cancer Immunoimaging with Smart Nanoparticles.
Ou YC, Wen X, Bardhan R. Ou YC, et al. Trends Biotechnol. 2020 Apr;38(4):388-403. doi: 10.1016/j.tibtech.2019.11.001. Epub 2019 Dec 5. Trends Biotechnol. 2020. PMID: 31812371 Review.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T; RANGE study investigators. Petrylak DP, et al. Among authors: ou yc. Lancet Oncol. 2020 Jan;21(1):105-120. doi: 10.1016/S1470-2045(19)30668-0. Epub 2019 Nov 18. Lancet Oncol. 2020. PMID: 31753727 Free PMC article. Clinical Trial.
Urologic cancer in Taiwan.
Hung CF, Yang CK, Ou YC. Hung CF, et al. Among authors: ou yc. Jpn J Clin Oncol. 2016 Jul;46(7):605-9. doi: 10.1093/jjco/hyw038. Epub 2016 Apr 6. Jpn J Clin Oncol. 2016. PMID: 27052114 Review.
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.
Cha TL, Wu TT, Vogelzang NJ, Huang CY, Huang SP, Lin CC, Ou YC, Pang ST, Shen DH, Wu WJ, Chang WY. Cha TL, et al. Among authors: ou yc. J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16. J Formos Med Assoc. 2017. PMID: 29046247 Free article. Review.
Aspirin Induced Glioma Apoptosis through Noxa Upregulation.
Chang CY, Pan PH, Li JR, Ou YC, Wang JD, Liao SL, Chen WY, Wang WY, Chen CJ. Chang CY, et al. Among authors: ou yc. Int J Mol Sci. 2020 Jun 13;21(12):4219. doi: 10.3390/ijms21124219. Int J Mol Sci. 2020. PMID: 32545774 Free PMC article.
331 results